Revision as of 05:46, 9 August 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'UNII').← Previous edit |
Latest revision as of 01:38, 17 March 2023 edit undoCitation bot (talk | contribs)Bots5,427,484 edits Alter: chapter-url. URLs might have been anonymized. | Use this bot. Report bugs. | Suggested by AManWithNoPlan | #UCB_CommandLine |
(20 intermediate revisions by 14 users not shown) |
Line 1: |
Line 1: |
|
|
{{Short description|Pharmaceutical drug}} |
|
{{Drugbox |
|
{{Drugbox |
|
|
| Verifiedfields = changed |
⚫ |
| verifiedrevid = 379640063 |
|
|
|
| Watchedfields = changed |
⚫ |
| IUPAC_name = -8-azoniabicyclooctan-3-yl] 3-hydroxy-2-phenylpropanoate bromide |
|
|
⚫ |
| verifiedrevid = 443819210 |
⚫ |
| image = Fentonium bromide.png |
|
|
⚫ |
| IUPAC_name = -8-azoniabicyclooctan-3-yl] 3-hydroxy-2-phenylpropanoate bromide |
|
| width = 150 |
|
|
⚫ |
| image = Fentonium bromide.svg |
⚫ |
| CAS_number = 5868-06-4 |
|
|
|
| width = 200 |
⚫ |
| ATC_prefix = A03 |
|
|
|
|
⚫ |
| ATC_suffix = BB04 |
|
|
|
<!--Clinical data--> |
⚫ |
| UNII = 26BF4S8FO5 |
|
|
|
| tradename = |
⚫ |
| PubChem = 71534 |
|
|
| DrugBank = |
|
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
⚫ |
| C=31|H=34|Br=1|N=1|O=4 |
|
|
⚫ |
| pregnancy_category = |
|
| molecular_weight = 564.51 g/mol |
|
|
⚫ |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
⚫ |
| bioavailability = |
|
|
⚫ |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
⚫ |
| protein_bound = |
|
|
⚫ |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
⚫ |
| metabolism = |
|
|
⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
⚫ |
| elimination_half-life = |
|
|
|
| legal_status = |
|
| excretion = |
|
|
⚫ |
| routes_of_administration = |
|
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
|
|
|
|
⚫ |
| pregnancy_US = <!-- A / B / C / D / X --> |
|
|
|
<!--Pharmacokinetic data--> |
⚫ |
| pregnancy_category= |
|
|
⚫ |
| bioavailability = 1 |
⚫ |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
|
|
⚫ |
| protein_bound = |
⚫ |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
|
|
⚫ |
| metabolism = |
⚫ |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
|
|
⚫ |
| elimination_half-life = |
⚫ |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
|
|
| legal_status = |
|
| excretion = |
|
|
|
⚫ |
| routes_of_administration = |
|
|
|
<!--Identifiers--> |
|
|
| CAS_number_Ref = {{cascite|correct|??}} |
|
⚫ |
| CAS_number = 5868-06-4 |
|
⚫ |
| ATC_prefix = A03 |
|
⚫ |
| ATC_suffix = BB04 |
|
⚫ |
| PubChem = 71534 |
|
|
| DrugBank_Ref = {{drugbankcite|changed|drugbank}} |
|
|
| DrugBank = DB08978 |
|
|
| UNII_Ref = {{fdacite|correct|FDA}} |
|
⚫ |
| UNII = XS152O7VCZ |
|
|
|
|
|
<!--Chemical data--> |
|
⚫ |
| C=31 | H=34 | Br=1 | N=1 | O=4 |
|
}} |
|
}} |
|
'''Fentonium''' is a ] derivative. |
|
|
|
|
|
|
|
'''Fentonium bromide''' (]) is an ] and ] ] derivative.<ref>{{cite book | vauthors = Milne GW |title=Drugs: Synonyms and Properties |date=2002 |publisher=Ashgate |location=Aldershot, Hampshire, England |isbn=978-0-566-08491-1 |page=2785 |edition=2nd | chapter = Fentonium bromide | chapter-url=https://books.google.com/books?id=QxcoEAAAQBAJ&dq=Fentonium+bromide&pg=PA213}}</ref> In the US its patent number is 3,356,682.<ref>{{cite web |title= Fentonium|url=https://www.drugbank.ca/drugs/DB08978 |website=DrugBank|access-date=19 December 2016|date=17 August 2016}}</ref> It is sold by ] and ].<ref>{{cite web |title=Ulcesium (fentonium bromide) drug & pharmaceuticals. Ulcesium available forms, doses, prices |url=https://www.sdrugs.com/?c=drug&s=ulcesium&ingredient=fentonium%20bromide |website = sdrugs.com |access-date=19 December 2016}}</ref> |
|
|
|
|
|
==References== |
|
|
{{reflist}} |
|
|
|
|
|
|
|
|
|
{{Drugs for functional gastrointestinal disorders}} |
|
{{Drugs for functional gastrointestinal disorders}} |
|
|
{{Muscarinic acetylcholine receptor modulators}} |
|
|
|
|
|
] |
|
] |
Line 37: |
Line 55: |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
|
] |
|
|
|
|
|
|
|
|